Royal Canin previewed upcoming therapeutic nutrition products at the Veterinary Meeting & Expo (VMX) 2026, including a new diet for overweight diabetic cats and fresh food options.
The company introduced GLYCOADVANCED, a feline diet formulated with an increased nutrient-to-calorie ratio and designed to enable safe caloric restriction in overweight diabetic cats. Available in dry and wet diet offerings, GLYCOADVANCED is formulated to support vitality, healthy blood glucose levels and a healthy body weight. Weight reduction with a veterinary diet is a key part of management for overweight diabetic cats, helping to improve blood sugar levels and their general health and wellbeing.
Royal Canin also launched home care kits offering nutritional solutions designed to support pets following diagnoses related to dermatology, gastrointestinal and urinary conditions with a sampling of the diets for those conditions. The kits bridge the transition between diagnosis and subscription services and provide education for pet owners about nutrition compliance.
VMX attendees received an initial look at Royal Canin Veterinary Fresh Nutrition launching later in 2026, offering therapeutic products for gastrointestinal and dermatology conditions. The gently cooked format delivers nutritional solutions beyond current wet and dry formulas.
"VMX sets the tone for the year as we continue to support and empower veterinary professionals through the impact of therapeutic nutrition," said Dr. Todd East, director of veterinary affairs, Royal Canin North America. "From our dietary offerings to our ongoing support of learning and development for veterinarians and veterinary technicians, 2026 will continue to be a year of innovation for Royal Canin and commitment to the veterinary industry."
Royal Canin is a Mars, Incorporated brand.
